5-Chloro-2-cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid

Catalog No. :
ACPQAC079
CAS No. :
858956-26-0
Molecular Formula :
C8H7ClN2O3
Molecular Weight :
214.61

IUPAC Name:5-Chloro-2-cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid

5-Chloro-2-cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$1659.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-2-cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid
IUPAC Name5-Chloro-2-cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid
MDL No.MFCD19689709
Molecular FormulaC8H7ClN2O3
Molecular Weight214.61
SMILESO=C(C1=NC(C2CC2)=NC(O)=C1Cl)O
InChI KeyBFVDWJIMPJYKGH-UHFFFAOYSA-N
Synonym5-CHLORO-2-CYCLOPROPYL-6-OXO-1,6-DIHYDRO-PYRIMIDINE-4-CARBOXYLIC ACID;5-chloro-2-cyclopropyl-6-hydroxypyriMidine-4-carboxylic acid;5-Chloro-2-cyclopropyl-1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acid;4-Pyrimidinecarboxylic acid, 5-chloro-2-cyclopropyl-1,6-dihydro-6-oxo-;5-CHLORO-2-CYCLOPROPYL-6-OXO-1,6-DIHYDRO-PYRIMIDINE-4-CARBOXYLIC ACID ISO 9001:2015 REACH
CAS No.858956-26-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPQAC079 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDBTA920 route compound structure diagram
    ACDBTA920858956-25-9 In Stock
  2. Then
  3. ACPQAC079 route product structure diagram
    ACPQAC079858956-26-0
Inquiry

2. ACPQAC079 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDBTA920 route compound structure diagram
    ACDBTA920858956-25-9 In Stock
  2. Then
  3. ACPQAC079 route product structure diagram
    ACPQAC079858956-26-0
Inquiry

Comments (0)